Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia

Journal of Vascular Surgery

Volumn 39, Issue 3, 2004, Pages 621-628

  Palmer Kazen, Ulrika ^a,b   Wariaro, David ^a,b   Luo, Fuwen ^a,b   Wahlberg, Eric ^a,b  

^a Karolinska Hospital ^*

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CLINICAL ARTICLE; CONNECTIVE TISSUE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DRUG SCREENING; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROCNEMIUS MUSCLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; MUSCLE BIOPSY; MUSCLE CELL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SKIN BIOPSY;

EID: 1542346971     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2003.07.006     Document Type: Article

References (29)

1. Management of peripheral arterial disease (PAD). TransAtlantic InterSociety Consensus (TASC). Eur J Vasc Endovasc Surg 2000;19(suppl A).
2. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992;189:824-31.
3. Unger EF, Banai S, Shou M, Lazarous DF, Jaklitsch MT, Scheinowitz M, et al. bFGF enhances myocardial collateral flow in a canine model. Am J Physiol 1994;266:H1588-95.
4. Takeshita S, Pu L-Q, Stein LA, Sniderman AD, Bunting S, Ferrara N, et al. Intramuscular administration of vascular endothelial growth factor induces dose-dependent collateral artery augmentation in a rabbit model of chronic limb ischemia. Circulation 1994;90:II-228-34.
5. Kleiman NS, Califf RM. Results from late-breaking clinical trials sessions at ACCIS 2000 and ACC 2000. J Am Coll Cardiol 2000;36:310-25.
6. Lederman RJ, Mendelsohn FO, Anderson RD, Saucedo JF, Tenaglia AN, Hermiller JB, et al. Therapeutic angiogenesis with recombinant fibroblast growth factor-2 for intermittent claudication (the TRAFFIC study). Lancet 2002;359:2053-8.
7. Buschman I, Schaper W. The pathophysiology of the collateral circulation (arteriogenesis). J Pathol 2000;190:338-42.
8. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000;6:389-95.
9. Ito WD, Arras M, Scholz D, Winkler B, Htun P, Schaper W. Angiogenesis but not collateral growth is associated with ischemia after femoral artery occlusion. Am J Physiol Heart Circ Physiol 1997;273:H1255-65.
10. Semenza GL. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J Appl Physiol 2000;88:1474-80.
11. Liu Y, Cox SR, Morita T, Kourembanas S. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Circ Res 1995;77:638-43.
12. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of VEGF expression induced by myocardial ischemia: implications for coronary angiogenesis. Cardiovasc Res 1994;28:1176-9.
13. Rohovsky S, Kearney M, Pieczek A, Rosenfield K, Schainfeld R, D'Amore PA, et al. Elevated levels of bFGF in patients with limb ischemia. Am Heart J 1996;132:1015-9.
14. Schultz A, Lavie L, Hochberg I, Beyar R, Stone T, Skorecki K, et al. Interindividual heterogeneity in the hypoxic regulation of VEGF. Circulation 1999;100:547-52.
15. Vadiveloo PK, Filonzi EL, Stanton HR, Hamilton JA. G1 phase arrest of human smooth muscle cells by heparin, IL-4 and cAMP is linked to repression of cyclin D1 and cdk2. Atherosclerosis 1997;133:61-9.
16. Cherwek DH, Hopkins MB, Thompson MJ, Annex BH, Taylor DA. Fiber type-specific differential expression of angiogenic factors in response to chronic hindlimb ischemia. Am J Physiol Heart Circ Physiol 2000;279:H932-8.
17. Luo F, Wariaro D, Lundberg G, Blegen H, Wahlberg E. Vascular growth factor expression in a rat model of severe limb ischemia. J Surg Res 2002;108:258-67.
18. Hasdai D, Barak V, Leibovitz E, et al. Serum basic fibroblast growth factor levels in patients with ischemic heart disease. Int J Cardiol 1997;59:133-8.
19. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
20. Shinohara K, Shinohara T, Mochizuki N, Mochizuki Y, Sawa H, Kohya T, et al. Expression of VEGF in human myocardial infarction. Heart Vessels 1996;11:113-22.
21. Gustafsson T, Puntschart A, Kaijser L, Jansson E, Sundberg CJ. Exercise-induced expression of angiogenesis-related transcription and growth factors in human skeletal muscle. Am J Physiol Heart Circ Physiol 1999;276:H679-85.
22. Heba G, Krzeminski T, Porc M, Grzyb J, Ratajska A, Dembinska-Kiec A. The time course of tumor necrosis factor-α, inducible nitric oxide synthase and vascular endothelial growth factor expression in an experimental model of chronic myocardial infarction in rats. J Vasc Res 2001;38:288-300.
23. Hershey JC, Baskin EP, Glass JD, Hartman HA, Gilberto DB, Rogers IT, et al. Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis. Cardiovasc Res 2001;49:618-25.
24. Malamitsi-Puchner A, Sarandakou A, Tziotis J, Dafogianni C, Bartsocas CS. Serum levels of basic fibroblast growth factor and vascular endothelial growth factor in children and adolescents with type 1 diabetes mellitus. Pediatr Res 1998;44:873-5.
25. Zimering MB, Eng J. Increased basic fibroblast growth factor-like substance in plasma from a subset of middle-aged or elderly male diabetic patients with microalbuminuria or proteinuria. J Clin Endocrinol Metab 1996;81:4446-52.
26. Waltenberger J, Lange J, Kranz A. Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus. Circulation 2000;102:185-90.
27. Annex BH, Torgan CE, Lin P, Taylor DA, Thompson MA, Peters KG, et al. Induction and maintenance of increased VEGF protein by chronic motor nerve stimulation in skeletal muscle. Am J Physiol Heart Circ Physiol 1998;274:H860-7.
28. Rissanen TT, Vajanto I, Hiltunen MO, Rutanen J, Kettunen MI, Leppanen P, et al. Expression of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 (KDR/Flk-1) in ischemic skeletal muscle and its regeneration. Am J Pathol 2002;160:1393-403.
29. Niessen FB, Andriessen MP, Schalkwijk J, Wisser L, Tiemens W. Keratinocyte derived growth factors play a role in hypertrophic scars. J Pathol 2001;194:207-16.